NCT03622489

Brief Summary

Women undergoing elective cesarian section will be assigned to 3 groups for postoperative analgesia:

  1. 1.Scheduled doses of IV acetaminophen + PO Ibuprofen
  2. 2.Scheduled doses of PO acetaminophen + PO Ibuprofen
  3. 3."On demand" doses of acetaminophen, dipyrone and ibuprofen.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P75+ for phase_4 postoperative-pain

Timeline
Completed

Started Mar 2017

Typical duration for phase_4 postoperative-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2017

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

August 5, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 9, 2018

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2018

Completed
Last Updated

August 9, 2018

Status Verified

June 1, 2018

Enrollment Period

1.5 years

First QC Date

August 5, 2018

Last Update Submit

August 8, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Average pain score 48 hours following surgery: visual numerical scale (VNS)

    Using : visual numerical scale (VNS)

    48 hours

Study Arms (3)

Tab ibuprofen + IV acetaminophen

EXPERIMENTAL

All women will receive immediately after surgery, in the recovery room: 1. IV morphin 5 mg, repeat doses every 10 minutes for VNS\>3 2. IV Tramal 100 mg, once After Admitted to Maternity ward: \- Scheduled doses: 08:00 hr, Tab. Ibuprofen 400 mg, and IV Acetaminophen 1 gr 14:00 hr, IV Acetaminophen 1 gr 19:00 hr, Tab. Ibuprofen 400 mg 00:00 hr, IV Acetaminophen 1 gr -Additional analgesia if needed according to VNS scale: PO drops Dipyrone 1 gr, for VNS\>4, up to 4 times a day, at least 6 hours between doses. Tab Tramadex 100 mg, for VNS\>6, or if pain persists for 1 hour after receiving Dipyrone, up to 3 times a day, at least 4 hours between doses.

Drug: AcetaminophenDrug: Ibuprofen 400 mgDrug: TramadolDrug: MorphineDrug: Tramal

Tab Ibuprofen + Tab acetaminophen

EXPERIMENTAL

All women will receive immediately after surgery, in the recovery room: 1. IV morphin 5 mg, repeat doses every 10 minutes for VNS\>3 2. IV Tramal 100 mg, once After Admitted to Maternity ward: \- Scheduled doses: 08:00 hr, Tab. Ibuprofen 400 mg, and PO Acetaminophen 1 gr 14:00 hr, PO Acetaminophen 1 gr 19:00 hr, Tab. Ibuprofen 400 mg 00:00 hr, PO Acetaminophen 1 gr \- Additional analgesia if needed according to VNS scale: PO drops Dipyrone 1 gr, for VNS\>4, up to 4 times a day, at least 6 hours between doses. Tab Tramadex 100 mg, for VNS\>6, or if pain persists for 1 hour after receiving Dipyrone, up to 3 times a day, at least 4 hours between doses.

Drug: AcetaminophenDrug: Ibuprofen 400 mgDrug: TramadolDrug: MorphineDrug: Tramal

"On demand" analgesia

EXPERIMENTAL

All women will receive immediately after surgery, in the recovery room: 1. IV morphin 5 mg, repeat doses every 10 minutes for VNS\>3 2. IV Tramal 100 mg, once After Admitted to Mternity ward: Will not receive scheduled pain medication, but offered some only upon patients' request according to VNS score: * Tab. Acetaminophen 1 gr, for VNS 1-3, up to 4 times a day, at east 6 hours between doses. * PO drops Dipyrone 1 gr, for VNS 4-7, or if pain persists for 1 hour after receiving Acetaminophen, up to 4 times a day, at least 6 hours between doses. * Tab Ibuprofen 400 mg, for VNS 8-10, or if pain persists for 1 hour after receiving Dipyrone, up to 3 times a day, at least 8 hours between doses.

Drug: AcetaminophenDrug: Ibuprofen 400 mgDrug: DipyroneDrug: TramadolDrug: MorphineDrug: Tramal

Interventions

mentioned above

"On demand" analgesiaTab Ibuprofen + Tab acetaminophenTab ibuprofen + IV acetaminophen

mentioned above

"On demand" analgesiaTab Ibuprofen + Tab acetaminophenTab ibuprofen + IV acetaminophen

mentioned above

"On demand" analgesia

mentioned above

Also known as: Tramadex
"On demand" analgesiaTab Ibuprofen + Tab acetaminophenTab ibuprofen + IV acetaminophen

mentioned above

"On demand" analgesiaTab Ibuprofen + Tab acetaminophenTab ibuprofen + IV acetaminophen
TramalDRUG

mentioned above

"On demand" analgesiaTab Ibuprofen + Tab acetaminophenTab ibuprofen + IV acetaminophen

Eligibility Criteria

Age20 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women undergoing elective cesarian section

You may not qualify if:

  • known allergies to one or more of the studies' drugs, general anesthesia, woman undergoing her 3rd cesarean section or more, elective tubal ligation performed at the time of current cesarean section, contraindication for use of one or more of the studies' drugs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wolfson medical center

Holon, Israel

RECRUITING

Related Publications (1)

  • Dafna L, Herman HG, Ben-Zvi M, Bustan M, Sasson L, Bar J, Kovo M. Comparison of 3 protocols for analgesia control after cesarean delivery: a randomized controlled trial. Am J Obstet Gynecol MFM. 2019 May;1(2):112-118. doi: 10.1016/j.ajogmf.2019.04.002. Epub 2019 Apr 8.

MeSH Terms

Conditions

Pain, Postoperative

Interventions

AcetaminophenIbuprofenDipyroneTramadolMorphine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesPhenylpropionatesAcids, CarbocyclicCarboxylic AcidsAminopyrinePyrazolonesPyrazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsCyclohexanolsHexanolsFatty AlcoholsAlcoholsDimethylaminesMethylaminesLipidsMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic Compounds

Study Officials

  • Michal Kovo, MD

    Wolfson Medical Center

    STUDY CHAIR

Central Study Contacts

Lotem Dafna, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2018

First Posted

August 9, 2018

Study Start

March 1, 2017

Primary Completion

August 31, 2018

Study Completion

August 31, 2018

Last Updated

August 9, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will not share

Locations